Skip to main content
. Author manuscript; available in PMC: 2024 Jun 2.
Published in final edited form as: Nanoscale Horiz. 2022 Dec 20;8(1):10–28. doi: 10.1039/d2nh00289b

figure 3.

figure 3.

approaches using mrna-based therapeutics and vaccines for treatment of hcc. a) tumor suppressor gene and apoptotic protein encoding mrna leads to apoptosis of tumor cells and inhibition of tumor growth. b) immunostimulatory cytokines coded by mrna polarize macrophages to tumor-suppressive m1 state. c) cancer vaccines use mrna encoding tumor antigens to elicit immune response and prime t cells against these antigens.